Health Ministry Examines Stent Safety Concerns
Health ministry to investigate safety issues with Indian-made coronary stents after Sri Lanka's regulator withdraws three models.
The Economic Times · 1m
Cancer Drugs Get 30% Trade Margin Cap
Experts finalize cancer drugs list under 30% trade margin cap to save ₹2,500 crore annually.
The Economic Times · 1m
Govt Caps Anti-Cancer Drugs Trade Margins at 30% of MRP
Government to cap anti-cancer drug trade margins at 30% of MRP to reduce prices.
The Economic Times · 1m
Supreme Court backs Delhi HC orders in Daiichi-Fortis dispute
Supreme Court clears path for forensic audit in Daiichi-Fortis asset tracing.
The Economic Times · 1m
India drug regulator warns against prolonged painkiller and antibiotic use
India's drug regulator advises against long-term painkiller and antibiotic use to prevent kidney damage and antibiotic resistance.
The Economic Times · 1m
India's medical device rules to tighten safety enforcement
New rules could stop unsafe medical devices faster by letting regulators order destruction and halt sales
The Economic Times · 1m
India to add red warning labels to cough syrup bottles
New rules would ban use in children under four and require pictorial labels showing older kids.
The Economic Times · 1m
India moves to centralize sterile drug oversight
A proposal would bring all sterile medicines under central licensing to address contamination risks and regulatory fragmentation.
The Economic Times · 1m
India eases drug approval rules for generic manufacturers
New regulations will speed up bioequivalence studies and cut import licence processing times in half.
The Economic Times · 1m